Upregulation of plasma insulin-like growth factor binding protein 2 levels after biliopancreatic diversion in humans

Obesity

Volumn 20, Issue 7, 2012, Pages 1469-1473

  Li, Zhuo ^a,b   Martin, Julie ^a   Poirier, Paul ^a   Caron Cantin, Sarah Maude ^a   Hould, Frédéric Simon ^a   Marceau, Simon ^a   Marceau, Picard ^a   Picard, Frédéric ^a  

^a LAVAL UNIVERSITY   (Canada)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 2; TRIACYLGLYCEROL;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BODY FAT; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; OBESITY; OPERATION DURATION; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BODY COMPOSITION; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LEPTIN; MALE; OBESITY, MORBID; TIME FACTORS; TRIGLYCERIDES; UP-REGULATION; WEIGHT LOSS;

EID: 84862888260     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.90     Document Type: Article

References (33)

1. Thomas S, Schauer P. Bariatric surgery and the gut hormone response. Nutr Clin Pract 2010;25:175-182.
2. Woods P, Paquette C, Martin J et al. Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient. Cardiovasc Diabetol 2004;3:5.
3. Marceau P. Contribution of bariatric surgery to the comprehension of morbid obesity. Obes Surg 2005;15:3-10.
4. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006;9:497-507.
5. Poirier P, Cornier MA, Mazzone T et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation 2011;123:1683-1701.
6. Marceau P, Biron S, Hould FS et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis 2009;5:43-47.
7. Rubino F, Forgione A, Cummings DE et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749.
8. Salehi M, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptidve 1-stimulated postprandial insulin secretion in humans. Diabetes 2011;60:2308-2314.
9. Engl J, Sturm W, Sandhofer A et al. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. Eur J Clin Invest 2008;38:238-244.
10. Moschen AR, Molnar C, Wolf AM et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 2009;51:765-777.
11. Ress C, Tschoner A, Engl J et al. Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest 2010;40:277-280.
12. Boney CM, Moats-Staats BM, Stiles AD, D'Ercole AJ. Expression of insulinlike growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994;135:1863-1868.
13. Li Z, Picard F. Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. Horm Metab Res 2010;42: 787-791.
14. Arafat AM, Weickert MO, Frystyk J et al. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J Clin Endocrinol Metab 2009;94:5093-5101.
15. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009;20:153-162.
16. Wheatcroft SB, Kearney MT, Shah AM et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007;56:285-294.
17. Hedbacker K, Birsoy K, Wysocki RW et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010;11:11-22.
18. Claudio M, Benjamim F, Riccardo B et al. Adipocytes IGFBP-2 expression in prepubertal obese children. Obesity (Silver Spring) 2010;18:2055-2057.
19. Rasmussen MH, Juul A, Kjems LL, Hilsted J. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects. Eur J Endocrinol 2006;155:575-581.
20. Martin RM, Holly JM, Davey Smith G, Gunnell D. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. J Clin Endocrinol Metab 2006;91:3287-3295.
21. Nam SY, Lee EJ, Kim KR et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997;21:355-359.
22. Heald AH, Kaushal K, Siddals KW et al. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006;114:371-376.
23. Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Growth Horm IGF Res 2008;18:506-516.
24. Hoeflich A, Wu M, Mohan S et al. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 1999;140:5488-5496.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-E26.
27. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-322.
28. Frystyk J, Delhanty PJ, Skjaerbaek C, Baxter RC. Changes in the circulating IGF system during short-term fasting and refeeding in rats. Am J Physiol 1999;277:E245-E252.
29. Frühbeck G, Diez-Caballero A, Gómez-Ambrosi J et al. Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding. Obes Surg 2002;12:366-371.
30. Maruna P, Gürlich R, Fried M et al. Leptin as an acute phase reactant after non-adjustable laparoscopic gastric banding. Obes Surg 2001;11:609-614.
31. Mireuta M, Darnel A, Pollak M. IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription. Growth Factors 2010;28:243-255.
32. Martin JL, Baxter RC. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology 2007;148:2532-2541.
33. Mattar SG, Velcu LM, Rabinovitz M et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005;242:610-617; discussion 618-620.